Allosteric regulation by oleamide of the binding properties of 5- hydroxytryptamine7 receptors

Biochemical Pharmacology

Volumn 58, Issue 11, 1999, Pages 1807-1813

  Hedlund, Peter B ^a   Carson, Monica J ^a   Sutcliffe, J Gregor ^a   Thomas, Elizabeth A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Allosteric; Oleamide; Receptor; Regulation; Serotonin; Transfection

Indexed keywords

CLOZAPINE; CYCLIC AMP; METITEPINE; OLEAMIDE; OLEIC ACID; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN 7 RECEPTOR;

ALLOSTERISM; ARTICLE; DRUG ACTIVITY; DRUG INHIBITION; FRONTAL CORTEX; HELA CELL; HIPPOCAMPUS; HUMAN; HUMAN CELL; HYPOTHALAMUS; PRIORITY JOURNAL; RECEPTOR BINDING; SLEEP INDUCTION; SLEEP WAKING CYCLE;

ALLOSTERIC REGULATION; HELA CELLS; HUMANS; HYPNOTICS AND SEDATIVES; OLEIC ACIDS; RECEPTORS, SEROTONIN; TRANSFECTION;

EID: 0032702510     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00274-9     Document Type: Article

References (45)

1. Arafat E.S., Trimble J.W., Andersen R.N., Dass C., Desiderio D.M. Identification of fatty acid amides in human plasma. Life Sci. 45:1989;1679-1687.
2. Cravatt B.F., Prospero-Garcia O., Siuzdak G., Gilula N.B., Henriksen S.J., Boger D.L., Lerner R.A. Chemical characterization of a family of brain lipids that induce sleep. Science. 268:1995;1506-1509.
3. Lerner R.A., Siuzdak G., Prospero-Garcia O., Henriksen S.J., Boger D.L., Cravatt B.F. Cerebrodiene A brain lipid isolated from sleep-deprived cats . Proc Natl Acad Sci USA. 91:1994;9505-9509.
4. Bezuglov V.V., Bobrov M.Y., Archakov A.V. Bioactive amides of fatty acids. Biochemistry (Mosc). 63:1998;22-30.
5. 1A serotonin receptor potentiation by the biologically active lipid oleamide. Proc Natl Acad Sci USA. 95:1998;4102-4107.
6. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 258:1992;1946-1949.
7. Facci L., Dal Toso R., Romanello S., Buriani A., Skaper S.D., Leon A. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc Natl Acad Sci USA. 92:1995;3376-3380.
8. Hampson A.J., Bornheim L.M., Scanziani M., Yost C.S., Gray A.T., Hansen B.M., Leonoudakis D.J. Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission. J Neurochem. 70:1998;671-676.
9. Liu L., Lo Y.C., Chen I.J., Simon S.A. The responses of rat trigeminal ganglion neurons to capsaicin and two nonpungent vanilloid receptor agonists, olvanil and glyceryl nonamide. J Neurosci. 17:1997;4101-4111.
10. Wakamatsu K., Masaki T., Itoh F., Kondo K., Sudo K. Isolation of fatty acid amide as an angiogenic principle from bovine mesentery. Biochem Biophys Res Commun. 168:1990;423-429.
11. Horn TFW, Cravatt B, Patterson J, Boger D, Gombart L and Henriksen SJ, Effects of the sleep-inducing lipid oleamide on body temperature in rats. Soc Neurosci Abstr24 (Part 1): 696, 1998.
12. 7 neurons in mouse thalamus and hypothalamus. J Neurochem. 72:1999;2370-2378.
13. Huidobro-Toro J.P., Harris R.A. Brain lipids that induce sleep are novel modulators of 5-hydroxytryptamine receptors. Proc Natl Acad Sci USA. 93:1996;8078-8082.
14. Thomas E.A., Carson M.J., Neal M.J., Sutcliffe J.G. Unique allosteric regulation of 5-hydroxytryptamine receptor-mediated signal transduction by oleamide. Proc Natl Acad Sci USA. 94:1997;14115-14119.
15. 7) positively linked to adenylate cyclase. J Biol Chem. 268:1993;23422-23426.
16. 7) implicated in the regulation of mammalian circadian rhythms. Neuron. 11:1993;449-458.
17. 7A receptor. J Biol Chem. 273:1998;17469-17476.
18. 7 receptor in rat brain. Br J Pharmacol. 117:1996;657-666.
19. Mengod G., Vilaro M.T., Raurich A., Lopez-Gimenez J.F., Cortes R., Palacios J.M. 5-HT receptors in mammalian brain Receptor autoradiography and in situ hybridization studies of new ligands and newly identified receptors . Histochem J. 28:1996;747-758.
20. 7 receptor antagonist . J Med Chem. 41:1998;655-657.
21. 7) receptor isoforms in human and rat produced by alternative splicing Species differences due to altered intron-exon organization . J Neurochem. 68:1997;1372-1381.
22. 7(b)). Br J Pharmacol. 122:1997;126-132.
23. 7 receptor Cloning and pharmacological characterisation of two receptor variants . FEBS Lett. 413:1997;489-494.
24. 7 receptor agonist, on locomotor activity in golden hamster in constant darkness. Neurosci Lett. 210:1996;1-4.
25. Brewerton T.D. Toward a unified theory of serotonin dysregulation in eating and related disorders. Psychoneuroendocrinology. 20:1995;561-590.
26. Leonard B.E. Serotonin receptors and their function in sleep, anxiety disorders and depression. Psychother Psychosom. 65:1996;66-75.
27. Raible D.W., McMorris F.A. Induction of oligodendrocyte differentiation by activators of adenylate cyclase. J Neurosci Res. 27:1990;43-46.
28. Hedlund P.B., von Euler G. EasyBound - A user-friendly approach to nonlinear regression analysis of binding data. Comput Methods Programs Biomed. 58:1999;245-249.
29. Ehlert F.J. Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods. Mol Pharmacol. 33:1987;187-194.
30. 7 receptor, Orphan found. Trends Pharmacol Sci. 18:1997;104-107.
31. Deutsch S.I., Mastropaolo J., Hitri A. GABA-active steroids Endogenous modulators of GABA-gated chloride ion conductance . Clin Neuropharmacol. 15:1992;352-364.
32. Reynolds I.J., Miller R.J. Allosteric modulation of N-methyl-d-aspartate receptors. Adv Pharmacol. 21:1990;101-126.
33. A receptor channels, From subunits to functional entities. Curr Opin Neurobiol. 2:1992;263-269.
34. Costa E. Allosteric modulatory centers of transmitter amino acid receptors. Neuropsychopharmacology. 2:1989;167-174.
35. Jakubik J., Tucek S. Protection by alcuronium of muscarinic receptors against chemical inactivation and location of the allosteric binding site for alcuronium. J Neurochem. 63:1994;1932-1940.
36. Lee N.H., El-Fakahany E.E. Allosteric antagonists of the muscarinic acetylcholine receptor. Biochem Pharmacol. 42:1991;199-205.
37. Xu Z., Purdy R.E. Evidence for allosteric blockade of serotonergic receptors in rabbit thoracic aorta. J Pharmacol Exp Ther. 248:1989;1091-1095.
38. 2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide. Mol Pharmacol. 42:1992;826-830.
39. 2 receptor antagonists but allosteric modulators. Naunyn Schmiedebergs Arch Pharmacol. 335:1987;359-366.
40. 1) receptors . J Pharmacol Exp Ther. 267:1993;228-237.
41. 1B/1D receptors. Mol Pharmacol. 50:1996;752-762.
42. B-receptor subtypes assemble into functional heterodimer complexes. Nature. 396:1998;683-687.
43. BR2. Nature. 396:1998;674-679.
44. 2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J Biol Chem. 271:1996;16384-16392.
45. Jakubík J., Bacáková L., Lisá V., El-Fakahany E.E., Tucek S. Activation of muscarinic acetylcholine receptors via their allosteric binding sites. Proc Natl Acad Sci USA. 93:1996;8705-8709.